SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Accounts Receivable Narrative (Details) |
6 Months Ended | |
|---|---|---|
Jun. 30, 2024 |
Dec. 31, 2023 |
|
| Concentration Risk [Line Items] | ||
| Accounts receivable derived from Medicare | 54.00% | 69.00% |
| Net service revenue period of care payment rate (days) | 30 days | |
| Percentage of patient receivables outstanding | 10.00% | |
| Historical collection rate from Medicare | 99.00% | |
| Payor Concentration Risk | Accounts Receivable | Single Payor | ||
| Concentration Risk [Line Items] | ||
| Concentration risk (percent) | 14.00% |
| X | ||||||||||
- Definition Accounts Receivable, Portion Derived From Medicare No definition available.
|
| X | ||||||||||
- Definition Historical collection rate from Medicare. No definition available.
|
| X | ||||||||||
- Definition Description containing the number of days from the date the request for anticipated payment was received in which the final bill must be submitted to Medicare. No definition available.
|
| X | ||||||||||
- Definition Percentage of patient receivables outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|